NewAmsterdam Pharma Co N.V. (NAMS) stock
NAMSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NAMSW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.74+0.35 (+1.81%)
Close on Nov 18, 2026Market cap $2.36BP/E –Yield –
NewAmsterdam Pharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
NewAmsterdam Pharma's price to sales ratio was 342.3× on Nov 11, 2026, against 132.6× a year earlier. Over the last 4 years it ranged from 7.1× to 418.7×, with a median of 70.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 342.3× | +229.7 |
| 2025 | Dec 31, 2025 | 112.7× | +42.1 |
| 2024 | Dec 31, 2024 | 70.5× | +61.6 |
| 2023 | Dec 29, 2023 | 8.9× | – |
See a number that looks wrong?